quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:01:00·989d
PRRelease
Aldeyra Therapeutics Inc. logo
Gilead Sciences Inc. logo
Jazz Pharmaceuticals plc logo
+6

Ligand Reports Second Quarter 2023 Financial Results

ALDX· Aldeyra Therapeutics Inc.GILD· Gilead Sciences Inc.JAZZ· Jazz Pharmaceuticals plcLGND· Ligand Pharmaceuticals IncorporatedMRK· Merck & Company Inc.NOVN· Novan Inc.
Health Care
Original source

Companies

  • ALDX
    Aldeyra Therapeutics Inc.
    Health Care
  • GILD
    Gilead Sciences Inc.
    Health Care
  • JAZZ
    Jazz Pharmaceuticals plc
    Health Care
  • LGND
    Ligand Pharmaceuticals Incorporated
    Health Care
  • MRK
    Merck & Company Inc.
    Health Care
  • NOVN
    Novan Inc.
    Health Care
  • TVTX
    Travere Therapeutics Inc.
    Health Care
  • VKTX
    Viking Therapeutics Inc.
    Health Care
  • VRNA
    Verona Pharma plc
    Health Care

Recent analyst ratings

  • Apr 14TVTXUpdatePiper Sandler$49.00
  • Apr 10JAZZUpdateRaymond James$227.00
  • Mar 26VKTXUpdateWolfe Research-
  • Mar 18ALDXUpdateH.C. Wainwright$2.00
  • Mar 11LGNDUpdateBofA Securities$244.00
  • Mar 10GILDUpdateJefferies$180.00

Related

  • PR13m
    Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
  • INSIDER14h
    Chief Research Officer Rote William E. sold $355,719 worth of shares (9,100 units at $39.09) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 113,987 units (SEC Form 4)
  • PR1d
    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
  • PR1d
    Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026
  • PR1d
    Gilead Sciences to Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
  • PR1d
    Merck and Google Cloud Partner to Accelerate Agentic AI Enterprise Transformation
  • PR1d
    Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
  • PR2d
    Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022